Literature DB >> 33463551

Early T follicular helper cell activity accelerates hepatitis C virus-specific B cell expansion.

Eduardo Salinas1,2, Maude Boisvert3, Amit A Upadhyay2, Nathalie Bédard3, Sydney A Nelson4, Julie Bruneau3,5, Cynthia A Derdeyn2, Joseph Marcotrigiano6, Matthew J Evans7, Steven E Bosinger2,4, Naglaa H Shoukry3,8, Arash Grakoui1,2.   

Abstract

Early appearance of neutralizing antibodies during acute hepatitis C virus (HCV) infection is associated with spontaneous viral clearance. However, the longitudinal changes in antigen-specific memory B cell (MBCs) associated with divergent HCV infection outcomes remain undefined. We characterized longitudinal changes in E2 glycoprotein-specific MBCs from subjects who either spontaneously resolved acute HCV infection or progressed to chronic infection, using single-cell RNA-seq and functional assays. HCV-specific antibodies in plasma from chronically infected subjects recognized multiple E2 genotypes, while those from spontaneous resolvers exhibited variable cross-reactivity to heterotypic E2. E2-specific MBCs from spontaneous resolvers peaked early after infection (4-6 months), following expansion of activated circulating T follicular helper cells (cTfh) expressing interleukin 21. In contrast, E2-specific MBCs from chronically infected subjects, enriched in VH1-69, expanded during persistent infection (> 1 year), in the absence of significantly activated cTfh expansion. Early E2-specific MBCs from spontaneous resolvers produced monoclonal antibodies (mAbs) with fewer somatic hypermutations and lower E2 binding but similar neutralization as mAbs from late E2-specific MBCs of chronically infected subjects. These findings indicate that early cTfh activity accelerates expansion of E2-specific MBCs during acute infection, which might contribute to spontaneous clearance of HCV.

Entities:  

Keywords:  Adaptive immunity; B cells; Hepatitis; Immunology; Infectious disease

Year:  2021        PMID: 33463551      PMCID: PMC7810471          DOI: 10.1172/JCI140590

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  56 in total

1.  The receptor PD-1 controls follicular regulatory T cells in the lymph nodes and blood.

Authors:  Peter T Sage; Loise M Francisco; Christopher V Carman; Arlene H Sharpe
Journal:  Nat Immunol       Date:  2012-12-16       Impact factor: 25.606

Review 2.  T Follicular Helper Cell Biology: A Decade of Discovery and Diseases.

Authors:  Shane Crotty
Journal:  Immunity       Date:  2019-05-21       Impact factor: 31.745

3.  Peripheral blood B cell subset skewing is associated with altered cell cycling and intrinsic resistance to apoptosis and reflects a state of immune activation in chronic hepatitis C virus infection.

Authors:  Julia M Sugalski; Benigno Rodriguez; Susan Moir; Donald D Anthony
Journal:  J Immunol       Date:  2010-07-23       Impact factor: 5.422

4.  Broadly neutralizing antibodies with few somatic mutations and hepatitis C virus clearance.

Authors:  Justin R Bailey; Andrew I Flyak; Valerie J Cohen; Hui Li; Lisa N Wasilewski; Anna E Snider; Shuyi Wang; Gerald H Learn; Nurgun Kose; Leah Loerinc; Rebecca Lampley; Andrea L Cox; Jennifer M Pfaff; Benjamin J Doranz; George M Shaw; Stuart C Ray; James E Crowe
Journal:  JCI Insight       Date:  2017-05-04

5.  Human blood CXCR5(+)CD4(+) T cells are counterparts of T follicular cells and contain specific subsets that differentially support antibody secretion.

Authors:  Rimpei Morita; Nathalie Schmitt; Salah-Eddine Bentebibel; Rajaram Ranganathan; Laure Bourdery; Gerard Zurawski; Emile Foucat; Melissa Dullaers; SangKon Oh; Natalie Sabzghabaei; Elizabeth M Lavecchio; Marilynn Punaro; Virginia Pascual; Jacques Banchereau; Hideki Ueno
Journal:  Immunity       Date:  2011-01-06       Impact factor: 31.745

6.  Spontaneous control of primary hepatitis C virus infection and immunity against persistent reinfection.

Authors:  William O Osburn; Brian E Fisher; Kimberly A Dowd; Giselle Urban; Lin Liu; Stuart C Ray; David L Thomas; Andrea L Cox
Journal:  Gastroenterology       Date:  2009-09-24       Impact factor: 22.682

7.  Clearance of hepatitis C infection is associated with the early appearance of broad neutralizing antibody responses.

Authors:  William O Osburn; Anna E Snider; Brittany L Wells; Rachel Latanich; Justin R Bailey; David L Thomas; Andrea L Cox; Stuart C Ray
Journal:  Hepatology       Date:  2014-04-29       Impact factor: 17.425

8.  Virus-Specific CD4+ T Cells Have Functional and Phenotypic Characteristics of Follicular T-Helper Cells in Patients With Acute and Chronic HCV Infections.

Authors:  Bijan Raziorrouh; Kathrin Sacher; Rajiv G Tawar; Florian Emmerich; Christoph Neumann-Haefelin; Thomas F Baumert; Robert Thimme; Tobias Boettler
Journal:  Gastroenterology       Date:  2015-11-14       Impact factor: 22.682

9.  Memory CD8+ T cells are required for protection from persistent hepatitis C virus infection.

Authors:  Naglaa H Shoukry; Arash Grakoui; Michael Houghton; David Y Chien; John Ghrayeb; Keith A Reimann; Christopher M Walker
Journal:  J Exp Med       Date:  2003-06-16       Impact factor: 14.307

10.  BALDR: a computational pipeline for paired heavy and light chain immunoglobulin reconstruction in single-cell RNA-seq data.

Authors:  Amit A Upadhyay; Robert C Kauffman; Amber N Wolabaugh; Alice Cho; Nirav B Patel; Samantha M Reiss; Colin Havenar-Daughton; Reem A Dawoud; Gregory K Tharp; Iñaki Sanz; Bali Pulendran; Shane Crotty; F Eun-Hyung Lee; Jens Wrammert; Steven E Bosinger
Journal:  Genome Med       Date:  2018-03-20       Impact factor: 15.266

View more
  9 in total

Review 1.  T cell responses during HBV and HCV infections: similar but not quite the same?

Authors:  Naglaa H Shoukry; Christopher M Walker
Journal:  Curr Opin Virol       Date:  2021-10-04       Impact factor: 7.121

Review 2.  A Tale of Two Viruses: Immunological Insights Into HCV/HIV Coinfection.

Authors:  Samaa T Gobran; Petronela Ancuta; Naglaa H Shoukry
Journal:  Front Immunol       Date:  2021-08-12       Impact factor: 7.561

3.  Antibiotic Combined with Epitope-Specific Monoclonal Antibody Cocktail Protects Mice Against Bacteremia and Acute Pneumonia from Methicillin-Resistant Staphylococcus aureus Infection.

Authors:  LianLi Duan; Jinyong Zhang; Zhifu Chen; Qiang Gou; Qingshan Xiong; Yue Yuan; Haiming Jing; Jiang Zhu; Li Ni; Yuling Zheng; Zhiyong Liu; Xiaokai Zhang; Hao Zeng; Quanming Zou; Zhuo Zhao
Journal:  J Inflamm Res       Date:  2021-08-30

4.  Th1-Biased Hepatitis C Virus-Specific Follicular T Helper-Like Cells Effectively Support B Cells After Antiviral Therapy.

Authors:  Katharina Zoldan; Sabine Ehrlich; Saskia Killmer; Katharina Wild; Maike Smits; Marissa Russ; Anna-Maria Globig; Maike Hofmann; Robert Thimme; Tobias Boettler
Journal:  Front Immunol       Date:  2021-09-30       Impact factor: 7.561

5.  SARS-CoV-2-specific CD4+ T cells are associated with long-term persistence of neutralizing antibodies.

Authors:  Zhongfang Wang; Xiaoyun Yang; Xinyue Mei; Yumin Zhou; Zhiqiang Tang; Guichang Li; Jiaying Zhong; Mengqiu Yu; Mingzhu Huang; Xiaoling Su; Bijia Lin; Pengxing Cao; Ji Yang; Pixin Ran
Journal:  Signal Transduct Target Ther       Date:  2022-04-23

6.  Serum neutralization activity declines but memory B cells persist after cure of chronic hepatitis C.

Authors:  Akira Nishio; Sharika Hasan; Heiyoung Park; Nana Park; Jordan H Salas; Eduardo Salinas; Lela Kardava; Paul Juneau; Nicole Frumento; Guido Massaccesi; Susan Moir; Justin R Bailey; Arash Grakoui; Marc G Ghany; Barbara Rehermann
Journal:  Nat Commun       Date:  2022-09-16       Impact factor: 17.694

Review 7.  Where do T cell subsets stand in SARS-CoV-2 infection: an update.

Authors:  Mohammad Tarique; Mohd Suhail; Huma Naz; Naoshad Muhammad; Shams Tabrez; Torki A Zughaibi; Adel M Abuzenadah; Anwar M Hashem; Hari Shankar; Chaman Saini; Alpana Sharma
Journal:  Front Cell Infect Microbiol       Date:  2022-08-10       Impact factor: 6.073

Review 8.  Where to Next? Research Directions after the First Hepatitis C Vaccine Efficacy Trial.

Authors:  Christopher C Phelps; Christopher M Walker; Jonathan R Honegger
Journal:  Viruses       Date:  2021-07-13       Impact factor: 5.818

Review 9.  Towards a Systems Immunology Approach to Understanding Correlates of Protective Immunity against HCV.

Authors:  Naglaa H Shoukry
Journal:  Viruses       Date:  2021-09-18       Impact factor: 5.048

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.